Ani Pharmaceuticals, Inc
$1.63B- Market cap
- $1.60B
- Debt
- +$309.11M
- Cash
- −$285.59M
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIP · current priceP/E 21.45x
$71.23Latest market snapshot
Implied fair value · at LYFT's multiple
$8.1588.6% below market
3.32 ANIP EPS (TTM)×2.46x LYFT P/E=$8.15
Market $71.23Implied $8.15
LYFT · current priceP/E 2.46x
$16.72Latest market snapshot
Implied fair value · at ANIP's multiple
$146.11773.8% above market
6.81 LYFT EPS (TTM)×21.45x ANIP P/E=$146.11
Market $16.72Implied $146.11